• Profile
Close

Identification of driver genes and key pathways of glioblastoma demonstrates JNJ-7706621 as a novel anti-glioblastoma drug

World Neurosurgery Oct 11, 2017

Zhong S, et al. - This study was planned to assess the novel targets of diagnosis, therapy and prognosis for glioblastoma, as well as to verify the therapeutic effect of JNJ-7706621 regarding to glioblastoma. In comparison to human normal glial cell, glioblastoma cells expressed significantly high AURKA (Aurora kinase), nuclear division cycle 80 (NDC80), kinesin super-family protein 4A (KIF4A), and nucleolar and spindle-associated protein 1 (NUSAP1). Patients with low-expression of those four genes had a favorable prognosis. In treatment of glioblastoma patients, JNJ-7706621 proved a potential drug.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay